Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2021-06-17 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于使用可转换公司债券闲置募集资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle raised funds from convertible bonds to purchase financial products, specifically structured deposits. It includes detailed financial figures, descriptions of the financial products, risk assessments, approvals from the board and shareholders, and the impact on the company's finances. The document is not a full financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement about the company's capital management activities related to financing and investment of raised funds. This fits best under the category of Capital/Financing Update (CAP), as it provides updates on the company's use of raised capital and related financial activities.
2021-06-17 Chinese
益丰药房关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 益丰大药房连锁股份有限公司 regarding the completion of industrial and commercial registration changes, including changes to registered capital, business scope, and amendments to the company articles. It references a previous announcement about these changes and provides updated company registration details such as legal representative, registered capital, business scope, and address. The document is short (1322 characters) and does not contain financial statements or detailed financial data. It is a formal regulatory announcement about company registration changes rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-06-01 Chinese
益丰药房2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from Yifeng Pharmacy Chain Co., Ltd. regarding the implementation of the 2020 annual equity distribution plan, including cash dividends and stock bonus distribution. It details dividend per share, stock transfer ratios, relevant dates for dividend distribution, tax treatment, and changes in share capital structure. The document is titled as an "Implementation Announcement" and provides specific dividend amounts, payment dates, and shareholder meeting approval dates. It does not contain full financial statements or comprehensive financial performance data but focuses on dividend distribution details. Therefore, it fits the category of a Notice of Dividend Amount (DIV). The document length is about 3108 characters, consistent with a detailed dividend announcement rather than a full annual report or interim report.
2021-05-30 Chinese
湖南启元律师事务所关于益丰大药房连锁股份有限公司2020年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2020 Annual General Meeting (AGM) of Yifeng Pharmacy Chain Co., Ltd. It details the legality and validity of the AGM's convening, attendance, voting procedures, and results. The document is not the AGM materials or presentations themselves, nor is it the official voting results announcement. It is a legal opinion on the AGM process. Given the content and purpose, this document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the validation and legal opinion on the AGM voting process and results. The document length is 4120 characters, which is relatively short but contains substantive legal opinion rather than just an announcement of a report publication. Therefore, it is not a Report Publication Announcement (RPA). It is not an Annual Report (10-K), nor an Audit Report (AR), nor a Management Report (MDA). It is not a Proxy Solicitation (PSI) or AGM Information (AGM-R) because it does not contain the AGM materials or presentations but focuses on the legal opinion on the AGM voting process and results. Hence, the best classification is DVA with high confidence.
2021-05-20 Chinese
益丰药房2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2020 Annual General Meeting (AGM) of Yifeng Pharmacy Chain Co., Ltd. It details the meeting date, attendance, voting results on various proposals including the 2020 annual report, financial statements, profit distribution, and other corporate matters. The document is a formal announcement of the voting results and resolutions passed at the AGM, not the full annual report or financial statements themselves. The length is under 5,000 characters and it primarily reports on the meeting outcomes and voting tallies. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-20 Chinese
益丰药房关于2019年限制性股票激励计划部分限制性股票回购注销实施的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from a company regarding the repurchase and cancellation of restricted shares under a 2019 restricted stock incentive plan. It details the reasons for the repurchase, the number of shares involved, the decision-making process, legal opinions, and the impact on the company's share structure. The content focuses on share repurchase and cancellation activities related to stock incentives, not on financial results, management changes, or other report types. The document length is 2661 characters, which is relatively short but contains substantive information about the share repurchase and cancellation. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or sales of its own shares, including cancellations.
2021-05-16 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.